A Drug for Advanced Melanoma Is Found to Prolong Patients’ Lives


June 4, 2012

A Drug for Advanced Melanoma Is Found to Prolong Patients’ Lives New York Times - A new type of drug prolonged the lives of patients with advanced melanoma in a clinical trial, potentially adding to a growing number of therapies for a disease that was once nearly untreatable. “In melanoma, we are living something incredible,” Dr. Caroline Robert, lead investigator of the study, said after a news conference Sunday at the American Society of Clinical Oncology meeting here. The new drug, GlaxoSmithKline’s trametinib, also kept the disease from worsening longer than chemotherapy did, said Dr. Robert, who is the head of dermatology at the Institut Gustave Roussy in Villejuif, France.
New York Times article